Ionis Pharmaceuticals Inc

IONS: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
?<#LOCK|cH#^?LOCK|y?>^g#

Ionis: FDA Approves Rare-Disease Drug Dawnzera; Positive Long-Term Outlook and Shares Undervalued

Ionis received approval from the US Food and Drug Administration for Dawnzera (pipeline candidate donidalorsen), marking the first and only RNA-targeted prophylactic treatment for hereditary angioedema, or HAE.

Sponsor Center